Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Ritlecitinib can help about 14,000 people with severe hair loss.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

FFA can be mistaken for rosacea, requiring specific treatment for accurate diagnosis and management.

Gefitinib can cause hair loss without scarring.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

The method produces finasteride with a 92% yield.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

The new method makes finasteride production cheaper and safer for industry.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Finasteride crystals are held together by hydrogen bonds and weak interactions, forming synthon pseudopolymorphs.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

There are various treatment options for frontal fibrosing alopecia.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Finasteride effectively treats hair loss and prostate issues by blocking a specific enzyme.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Oral dutasteride is a recommended first treatment for frontal fibrosing alopecia.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Jamogenin from plants may help hair growth and is a potential alternative to finasteride.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

A treatment called Cellcurin, combined with microneedling, significantly increased hair density and diameter in patients with hair loss.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.